Navigation Links
Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
Date:7/8/2008

armasset.com">kurt.leutzinger@pharmasset.com

Office: +1 (609) 613-4110

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation the risk that Clevudine will not demonstrate any additive antiviral benefit in combination with tenofovir in the head-to-head study, the risk that Clevudine will not demonstrate superiority over Hepsera in Clevudine's ongoing Phase 3 registration study, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2007 filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commission.

Viread and Hepsera are registered trademarks of Gilead Sciences, Inc.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Receives Notice of Allowance
2. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
3. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
4. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
5. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
8. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
9. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
10. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... YORK , April 1, 2015   AMC ... solutions, will showcase advances in monitored care that are ... upcoming HIMSS 2015 Conference. The conference will ... , from April 12 through 16. In addition ... their respective booths, AMC Health will share innovations that ...
(Date:4/1/2015)...  Daiichi Sankyo, Inc., the US subsidiary of Daiichi ... with its US-based sister company, Asubio Pharmaceuticals, Inc.  As ... into the Daiichi Sankyo global development organization, led by ... Asubio Pharmaceuticals, parent company, Asubio Pharma Co., Ltd, which ... continue to operate as a wholly owned subsidiary of ...
(Date:4/1/2015)... Columbia and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... Erich Mohr , Ph.D., R.Psych., to its Board ... Mohr has close to two decades of biotechnology experience ... chief executive officer and board member, including serving as ...
Breaking Medicine Technology:AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 2AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 3AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 4Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge 2DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 2DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 3DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 4
... March 6, 2012   Sunpeaks Ventures, Inc. ... Ventures") is pleased to provide this corporate update ... Ventures, through the recent acquisition of its wholly ... the specialty drug distribution sector.  The U.S. pharmaceutical ...
... 6, 2012  Marshall Edwards, Inc. (Nasdaq: MSHL ... of novel therapeutics targeting cancer metabolism, announced today that ... to the U.S. Food and Drug Administration (FDA) to ... Company,s lead mitochondrial inhibitor. "I am ...
Cached Medicine Technology:Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector 2Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector 3Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344 2Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344 3
(Date:4/1/2015)... (PRWEB) April 01, 2015 Skin cancer is ... be cured if caught early. Forefront Dermatology and Dermatology Associates ... this dangerous condition before it spreads so they are hosting ... April 11th from 8:30am - 12:30pm. , “If we ... identify areas of concern, that could become cancerous,” said Dr. ...
(Date:4/1/2015)... It is the meat that has become an ... wrapped around other foods, infused into cocktails and even made ... the gateway meat for vegetarians and the perfect food. To ... Meat Institute (NAMI) has developed a new Ultimate Guide ... bacon processing plant and companion brochure with ...
(Date:4/1/2015)... April 01, 2015 Nike Tennis Camps ... boys and girls ages 10-17, providing campers with the ... Players will experience all 4 Grand Slam surfaces on ... home of Great Britain’s Davis Cup team and national ... of Richmond Park, the National Tennis Centre is the ...
(Date:4/1/2015)... Fork, UT (PRWEB) April 01, 2015 Pricing ... in the last several months, bring coverage to a third ... in the states of Massachusetts, Kansas, and Iowa, and the first ... An imaging center in Dallas, TX was also added. , In ... Traffic to and general interest in the platform continue to ...
(Date:4/1/2015)... Doctors in Italy have just published research ... against mesothelioma at higher doses. Surviving Mesothelioma has just ... Click here to read it now. , The ... of Siena with unresectable advanced mesothelioma whose ... patients received monthly doses of tremelimumab (instead of every ...
Breaking Medicine News(10 mins):Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2Health News:New Ultimate Guide to Bacon Video Provides Inside Look at How Bacon is Made 2Health News:US Sports Camps and Nike Tennis Camps to Launch in London, England this Summer 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 2Health News:PricingHealthcare.com Adds Facilities in 5 States, Hits 10,000 Monthly Users Milestone 3Health News:New Research Finds Immunotherapy Drug May Fight Mesothelioma Better at Higher Doses, According to Surviving Mesothelioma 2
... Linkage between the two might be genetic, researchers say , , ... history of melanoma are twice as likely to develop Parkinson,s ... this association are not clear, other studies have shown that ... melanoma. , "For people with a family member with melanoma, ...
... PHILADELPHIA, Feb. 16 Elderly patients who undergo ... than at nonteaching hospitals, but these better survival ... patients. "We found an advantage in surgical outcomes ... hospitals, as we had expected from other studies," ...
... more from improved expertise after surgery, but reasons unclear, ... White patients are less likely to die of post-surgery ... that benefit doesn,t apply to black patients, a U.S. ... Outcomes Research at The Children,s Hospital of Philadelphia and ...
... for technological breakthroughsCLEVELAND, Feb. 16 NorTech, in ... pleased to announce the winners of its annual ... of Northeast Ohio innovators who are impacting the ... the world. This year, a distinguished panel of ...
... victimized as recessions occur, study shows , , MONDAY, Feb. ... certain minority groups suffer at the hands of criminals ... National crime statistics from 1973 to 2005 show ... Latinos during and after periods of recession, according to ...
... twins were conjoined from the breast bone to the ... pediatricians and nurses at Children,s Hospital of Pittsburgh of ... procedure.The 2-year-old twin girls -- Dagian and Danielle Lee, ... began at 6:30 a.m. Saturday, Dec. 13, 2008, and ...
Cached Medicine News:Health News:Family History of Melanoma Doubles Parkinson's Risk 2Health News:White Patients Benefit More Than Blacks in Surviving Surgical Complications at Teaching Hospitals 2Health News:White Patients Benefit More Than Blacks in Surviving Surgical Complications at Teaching Hospitals 3Health News:Teaching Hospitals' Post-Op Gains Not Extended to Blacks 2Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 2Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 3Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 4Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 5Health News:Conjoined Twins Separated by Surgical Team at Children's Hospital of Pittsburgh of UPMC During Complex, 24-Hour Procedure 2
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
... Sheet. Medpor Sheets are commonly used ... craniofacial applications. The thinner 0.4 mm ... surgeon with greater flexibility and to ... insertion into the orbit. It is ...
... precise punching of the donor corneal ... use with disposable trephine blades. Unique ... centration of the donor tissue. Recessed ... held centrally under the trephine blade. ...
... violet ink stands up ... scale ruler printed on ... quick measuring. Flexible, smudge-proof ... inch and metric scales. ...
Medicine Products: